|
||
|
Business Development
Immunotope
is seeking commercial partnerships with biotechnology and pharmaceutical
companies that develop immunotherapeutic vaccines, monoclonal antibody
therapeutics and diagnostic tests for cancer and infectious diseases. Antigens
available for outlicensing We
have a variety of novel antigens available for clinical evaluation and outlicensing:
Lung cancer antigens
Pancreatic cancer antigens Platinum resistant ovarian cancer antigens Antibody
therapeutic targets Cancer
diagnostic targets
|
|
..................................................................................................................................................................... |